[Treatment of neurological forms of Argentinian hemorrhagic fever with cytarabine]. / Traitement des formes nerveuses de la fièvre hémorragique argentine par la cytarabine.

The effects of cytarabine on neurological forms of Argentina Hemorrhagic Fever were evaluated in 125 patients. The mortality was 12.88 per cent compared to 61.40 per cent in untreated patients. (p less than 0.0001). The efficiency of this treatment depends on its early application. No side effect was observed.

[Treatment of Argentine hemorrhagic fever with convalescent's plasma. 4433 cases]. / Traitement de la fièvre hémorragique argentine par le plasma de convalescent. 4,433 cas.

During the 23 consecutive annual epidemics of Argentine haemorrhagic fever observed from 1959 to 1983, a group of 4,433 patients were treated at Junin (Argentina) with convalescent's plasma; the overall mortality rate was 3.29%. In 1958, before convalescent's plasma was used, the mortality rate in 448 patients who received the conventional treatment was 42.85%. The difference between the two groups is highly significant and demonstrates the value of convalescent's plasma in the treatment of the disease.